Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02081144 · ClinicalTrials.gov registry record · Phase 1
Texting to Promote Tobacco Abstinence in Emergency Department Smokers: A Pilot Study
A Phase 1 study, sponsored by Yale University.
- Completed
- Registry status
- Phase 1
- Development phase
- 60
- Enrollment target
NCT02081144 is a Phase 1 study that has completed, run by Yale University. The registered enrollment target is 60 participants.
The verdict
NCT02081144, a Phase 1 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 60 participants
- Enrollment target
Study Summary
This is a pilot study to test the feasibility of conducting a text based smoking cessation trial with Emergency Department patients who are smokers.
Interventions
- DRUG nicotine replacement patches
- OTHER Smokefree TXT Program
- DRUG Nicotine Replacement Gum
- BEHAVIORAL Faxed Referral CT Smokers Quitline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2014-05 |
| Est. Completion | 2014-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02081144
The ClinicalTrials.gov registry entry for NCT02081144 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which nicotine replacement patches is the first listed.
NCT02081144 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02081144 about?
NCT02081144 is a clinical study titled "Texting to Promote Tobacco Abstinence in Emergency Department Smokers: A Pilot Study". This is a pilot study to test the feasibility of conducting a text based smoking cessation trial with Emergency Department patients who are smokers.
What is the current status of trial NCT02081144?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 60 participants. The study started on 2014-05. Estimated completion is 2014-10.
What interventions are being tested in trial NCT02081144?
The interventions under investigation include: nicotine replacement patches (DRUG), Smokefree TXT Program (OTHER), Nicotine Replacement Gum (DRUG), Faxed Referral CT Smokers Quitline (BEHAVIORAL).
Who is sponsoring clinical trial NCT02081144?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.